Lujia Chen
Ph.D. researcher formerly affiliated with the University of California, Irvine
Data updated
Papers
Trials
Research Footprint
Lujia Chen appears in 5 tracked papers (2018–2022), most studied alongside Ketamine, Ibogaine and Esketamine, across Depressive Disorders, Anxiety Disorders and Treatment-Resistant Depression (TRD).
Most-cited paper: Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression (179 citations).
Frequent co-authors: Yuping Ning, Chengyu Wang and Madeline Li.
Background & Research
Lujia Chen appears in the author lists of multiple neuroscience and psychopharmacology papers from the UC Irvine cortical circuit/plasticity ecosystem, including work on subanesthetic ketamine and a psychedelic analog that restores stress-disrupted neural circuits. UC Irvine materials list Lujia Chen as a former Ph.D. candidate in Xiangmin Xu’s lab, indicating training in neural circuit research relevant to depression and psychedelic science. A Janssen paper on esketamine also lists a Li Chen author, but the ketamine/neural-circuit publications strongly point to Lujia Chen as the researcher matching your database records.
Key Impact
Contributed to influential work on ketamine and psychedelic-analog effects in cortical plasticity and antidepressant mechanisms.
Collaboration Network
12 collaborators· click a node to visit their profile
Full network →